Ann: SIRFLOX Awarded Oral Presentation at ASCO, page-13

scorpion agree with you.

As much as I believe there will be clarification and upside to this presentation there is no indication of this just because its been received as an oral presentation.

Its received as an oral presentation because its a well conducted study with a large series of patients and the results will be of interest whether positive or negative,

I for one believe it will be positive and given track record of company with growth sales, huge mount of papers pointing to upside of the spheres, and potential uses in endemic primary HCC will continue its upward trajectory long term..and perhaps following abstract release next week,